Study On Let's Talk (NCT07246083) | Clinical Trial Compass
CompletedNot Applicable
Study On Let's Talk
Singapore104 participantsStarted 2025-12-18
Plain-language summary
The goal of this experience sampling method study is to understand the effectiveness and user experience of the 'let's talk' forum-- a public platform designed by the Ministry of Health Office for Healthcare Transformation (MOHT) to provide just-in-time digital mental health support for youths. 'Let's Talk' is a joint initiative by MOHT, Ministry of Social and Family Development (MSF), National Council of Social Service (NCSS), and the Institute of Mental Health (IMH) in Singapore.
Participants who meet the eligibility criteria (based on DASS-21 cutoff scores) will be invited to participate in Phase 2, which involves a 21-day intervention period involving the 'let's talk' forum. The experience sampling protocol involves sending prompts at regular intervals and monitoring anxiety levels.
Who can participate
Age range
18 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Phase 1 Screening Inclusion Criteria:
* Aged between 18-25 years if they are a student at the National University of Singapore (NUS); 21-25 years old if they are not a student at NUS
* Must have lived in SG for at least 2 years
* Have not received a formal diagnosis of a psychiatric disorder
* Not currently receiving any form of mental health treatment (e.g., counselling)
Phase 2 Experience Sampling Inclusion Criteria:
\- Partiicpants from Phase 1 whose DASS-21 scores are at least moderate for any one of the following sub scales (cut off of 14 for depression, 10 for anxiety, and 19 for stress).
Phase 3 Focus Group Discussions Inclusion Criteria:
* Existing befrienders or peer supporters on the let's talk site (aged 21-80)
* Agree to audio and video recording of FGD
* Individuals who have completed phase 2
Exclusion Criteria:
* Those who do not meet the inclusion criteria will be screened and excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Mental health symptoms: Measured through the 21-item Depression, Anxiety and Stress Scale (DASS-21)
Timeframe: Screening
2
Awareness, views and prior usage of mental health services
Timeframe: Screening, 4 weeks after baseline, 8 weeks after baseline
3
Attitudes, knowledge and behaviors regarding mental health and help-seeking
Timeframe: Baseline, 4 weeks after baseline, 8 weeks after baseline
4
STAI Rating
Timeframe: Daily over 21 days
5
Emotion Regulation
Timeframe: 4 weeks after baseline, 8 weeks after baseline
6
Attitudes, knowledge and behaviors regarding mental health and help-seeking
Timeframe: Baseline, 4 weeks after baseline, 8 weeks after baseline
7
Emotion regulation
Timeframe: 4 weeks after baseline, 8 weeks after baseline
Trial details
NCT IDNCT07246083
SponsorCentre for Evidence and Implementation Singapore Ltd